Statement by FDA Commissioner Scott Gottlieb, M.D., Director of FDA's Center for Drug Evaluation and Research Janet Woodcock, M.D. and Director of FDA's Center for Biologics Evaluation and Research Peter Marks, M.D. on Expanded Access -Looking Forward

SILVER SPRING: U.S. Food and Drug Administration has issued the following news release: For more than 30 years, the FDA has supported patients' access to investigational medical products for treatment, [...]